title: Novel mutation in STXBP2 prevents IL-2-induced natural killer cell cytotoxicity.
authors.forename: Rushani W
authors.initials: RW
authors.lastname: Saltzman
authors.forename: Linda
authors.initials: L
authors.lastname: Monaco-Shawver
authors.forename: Kejian
authors.initials: K
authors.lastname: Zhang
authors.forename: Kathleen E
authors.initials: KE
authors.lastname: Sullivan
authors.forename: Alexandra H
authors.initials: AH
authors.lastname: Filipovich
authors.forename: Jordan S
authors.initials: JS
authors.lastname: Orange
mesh_terms: D002460:Cell Line; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006801:Humans; D007223:Infant; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology*; D008297:Male; D051938:Munc18 Proteins / Q000235:genetics*; D009154:Mutation; D010375:Pedigree; D014429:Twins, Dizygotic
chemical_list: D007376:Interleukin-2; D051938:Munc18 Proteins; C497940:STXBP2 protein, human